Anomalous payload-based network intrusion detection
K Wang, SJ Stolfo - International workshop on recent advances in …, 2004 - Springer
We present a payload-based anomaly detector, we call PAYL, for intrusion detection. PAYL
models the normal application payload of network traffic in a fully automatic, unsupervised …
models the normal application payload of network traffic in a fully automatic, unsupervised …
Privacy-preserving data publishing: A survey of recent developments
… key and k-anonymity on QID fails to ensure that each group on QID contains at least k (distinct) …
patient has at least 3 diseases, a group of k records will involve no more than k/3 patients. …
patient has at least 3 diseases, a group of k records will involve no more than k/3 patients. …
In vivo three-photon microscopy of subcortical structures within an intact mouse brain
Two-photon fluorescence microscopy 1 enables scientists in various fields including neuroscience
2 , 3 , embryology 4 and oncology 5 to visualize in vivo and ex vivo tissue morphology …
2 , 3 , embryology 4 and oncology 5 to visualize in vivo and ex vivo tissue morphology …
[HTML][HTML] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
…, Q Lu, Y Hu, G Luo, K Wang, Y Lu, H Li, S Wang… - The lancet, 2020 - thelancet.com
Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …
[PDF][PDF] Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography
Many COVID-19 patients infected by SARS-CoV-2 virus develop pneumonia (called novel
coronavirus pneumonia, NCP) and rapidly progress to respiratory failure. However, rapid …
coronavirus pneumonia, NCP) and rapidly progress to respiratory failure. However, rapid …
A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19
B Cao, Y Wang, D Wen, W Liu, J Wang… - New England journal …, 2020 - Mass Medical Soc
Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label …
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
X Li, S Xu, M Yu, K Wang, Y Tao, Y Zhou, J Shi… - Journal of Allergy and …, 2020 - Elsevier
Background In December 2019, the coronavirus disease 2019 (COVID-19) outbreak occurred
in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID…
in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID…
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
…, Z Wang, CF Wang, Y Lu, YY Liu, QY Wang… - Signal transduction and …, 2020 - nature.com
In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2,
no specific and effective drugs for treating this disease have been reported until today. …
no specific and effective drugs for treating this disease have been reported until today. …
[HTML][HTML] Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions
…, Y Xie, B Liu, Z Wang, S Zhang, Y Wang… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan,
Hubei province, China, coincided with chunyun, the period of mass migration for the annual …
Hubei province, China, coincided with chunyun, the period of mass migration for the annual …
